Deficiency of Nuclear Receptor Coactivator 3 Aggravates Diabetic Kidney Disease by Impairing Podocyte Autophagy. | Deficiency of Nuclear Receptor Coactivator 3 Aggravates Diabetic Kidney Disease by Impairing Podocyte Autophagy. Xie Y, Yuan Q, Cao X, Qiu Y, Zeng J, Cao Y, Xie Y, Meng X, Huang K, Yi F, Zhang C., Free PMC Article | 06/7/2024 |
Protective role of circRNA CCND1 in ulcerative colitis via miR-142-5p/NCOA3 axis. | Protective role of circRNA CCND1 in ulcerative colitis via miR-142-5p/NCOA3 axis. Xiang P, Ge T, Zhou J, Zhang Y., Free PMC Article | 01/28/2023 |
ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma. | ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma. Han R, Dermawan JK, Demicco EG, Ferguson PC, Griffin AM, Swanson D, Antonescu CR, Dickson BC., Free PMC Article | 09/17/2022 |
NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways. | NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways. Li Y, Liang J, Dang H, Zhang R, Chen P, Shao Y. | 03/26/2022 |
PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients. | PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients. Jahangiri R, Mosaffa F, Emami Razavi A, Teimoori-Toolabi L, Jamialahmadi K. | 02/12/2022 |
Non-Syndromic Autosomal Dominant Hearing Loss: The First Italian Family Carrying a Mutation in the NCOA3 Gene. | Non-Syndromic Autosomal Dominant Hearing Loss: The First Italian Family Carrying a Mutation in the NCOA3 Gene. Tesolin P, Morgan A, Notarangelo M, Ortore RP, Concas MP, Notarangelo A, Girotto G., Free PMC Article | 02/5/2022 |
FBXL16 modulates the proliferation and autophagy in breast cancer cells via activating SRC-3-AKT signaling pathway. | FBXL16 modulates the proliferation and autophagy in breast cancer cells via activating SRC-3-AKT signaling pathway. Yang M, Jing F. | 01/29/2022 |
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer. | An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer. Sharif GM, Campbell MJ, Nasir A, Sengupta S, Graham GT, Kushner MH, Kietzman WB, Schmidt MO, Pearson GW, Loudig O, Fineberg S, Wellstein A, Riegel AT., Free PMC Article | 01/8/2022 |
Functional relationship between CFTR and RAC3 expression for maintaining cancer cell stemness in human colorectal cancer. | Functional relationship between CFTR and RAC3 expression for maintaining cancer cell stemness in human colorectal cancer. Palma AG, Soares Machado M, Lira MC, Rosa F, Rubio MF, Marino G, Kotsias BA, Costas MA. | 12/25/2021 |
PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer. | PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer. Truong TH, Benner EA, Hagen KM, Temiz NA, Kerkvliet CP, Wang Y, Cortes-Sanchez E, Yang CH, Trousdell MC, Pengo T, Guillen KP, Welm BE, Dos Santos CO, Telang S, Lange CA, Ostrander JH., Free PMC Article | 12/25/2021 |
Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs. | Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs. Nikolai BC, Jain P, Cardenas DL, York B, Feng Q, McKenna NJ, Dasgupta S, Lonard DM, O'Malley BW., Free PMC Article | 11/13/2021 |
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility. | Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility. de Semir D, Bezrookove V, Nosrati M, Dar AA, Miller JR 3rd, Leong SP, Kim KB, Liao W, Soroceanu L, McAllister S, Debs RJ, Schadendorf D, Leachman SA, Cleaver JE, Kashani-Sabet M., Free PMC Article | 11/6/2021 |
A mutant form of ERalpha associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment. | A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment. Li Y, Coons LA, Houtman R, Carlson KE, Martin TA, Mayne CG, Melchers D, Jefferson TB, Ramsey JT, Katzenellenbogen JA, Korach KS., Free PMC Article | 10/30/2021 |
NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss. | NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss. Salazar-Silva R, Dantas VLG, Alves LU, Batissoco AC, Oiticica J, Lawrence EA, Kawafi A, Yang Y, Nicastro FS, Novaes BC, Hammond C, Kague E, Mingroni-Netto RC., Free PMC Article | 09/11/2021 |
SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells. | SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells. Hu M, Lu Y, Qi Y, Zhang Z, Wang S, Xu Y, Chen F, Tang Y, Chen S, Chen M, Du C, Shen M, Wang F, Su Y, Deng Y, Wang J. | 08/28/2021 |
Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. | Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. Li L, Bao J, Wang H, Lei JH, Peng C, Zeng J, Hao W, Zhang X, Xu X, Yu C, Deng CX, Chen Q., Free PMC Article | 08/21/2021 |
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype. | Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype. Varešlija D, Ward E, Purcell SP, Cosgrove NS, Cocchiglia S, O'Halloran PJ, Charmsaz S, Bane FT, Brett FM, Farrell M, Cryan J, Beausang A, Hudson L, Turnbul AK, Dixon JM, Hill ADK, Priedigkeit N, Oesterreich S, Lee AV, Sims AH, Redmond AM, Carroll JS, Young LS., Free PMC Article | 07/31/2021 |
SRC-3, a Steroid Receptor Coactivator: Implication in Cancer. | SRC-3, a Steroid Receptor Coactivator: Implication in Cancer. Li L, Deng CX, Chen Q., Free PMC Article | 05/29/2021 |
Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. | Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. Kushner MH, Ory V, Graham GT, Sharif GM, Kietzman WB, Thevissen S, Yuan M, Schmidt MO, Wellstein A, Riegel AT., Free PMC Article | 05/8/2021 |
Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer. | Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer. Oh JH, Lee JY, Kim KH, Kim CY, Jeong DS, Cho Y, Nam KT, Kim MH. | 03/28/2021 |
Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. | Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Liu J, Xie Y, Guo J, Li X, Wang J, Jiang H, Peng Z, Wang J, Wang S, Li Q, Ye L, Zhong Y, Zhang Q, Liu X, Lonard DM, Wang J, O'Malley BW, Liu Z., Free PMC Article | 02/27/2021 |
Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38(MAPK)-MK2 axis and affects NF-kappaB-mediated transcription. | Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38(MAPK)-MK2 axis and affects NF-κB-mediated transcription. Shrestha A, Bruckmueller H, Kildalsen H, Kaur G, Gaestel M, Wetting HL, Mikkola I, Seternes OM., Free PMC Article | 12/26/2020 |
SRC-3/AIB-1 may Enhance Hepatic NFATC1 Transcription and Mediate Inflammation in a Tissue-Specific Manner in Morbid Obesity. | SRC-3/AIB-1 may Enhance Hepatic NFATC1 Transcription and Mediate Inflammation in a Tissue-Specific Manner in Morbid Obesity. Chasapi A, Balampanis K, Tanoglidi A, Kourea E, Lambrou GI, Lambadiari V, Kalfarentzos F, Hatziagelaki E, Melachrinou M, Sotiropoulou-Bonikou G. | 11/21/2020 |
Hypoxia-induced Downregulation of SRC-3 Suppresses Trophoblastic Invasion and Migration Through Inhibition of the AKT/mTOR Pathway: Implications for the Pathogenesis of Preeclampsia. | Hypoxia-induced Downregulation of SRC-3 Suppresses Trophoblastic Invasion and Migration Through Inhibition of the AKT/mTOR Pathway: Implications for the Pathogenesis of Preeclampsia. He C, Shan N, Xu P, Ge H, Yuan Y, Liu Y, Zhang P, Wen L, Zhang F, Xiong L, Peng C, Qi H, Tong C, Baker PN., Free PMC Article | 10/31/2020 |
A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator. | A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator. Zheng X, Jia Y, Qiu L, Zeng X, Xu L, Wei M, Huang C, Liu C, Chen L, Han J., Free PMC Article | 10/24/2020 |